With help in the Parkinson’s Group they're going to hopefully be able to finish this study immediately and go forward to Period 2 to ascertain if their agent (Selnoflast) is possibly impacting progression. RECAP #2: Researchers have demonstrated that aspects with the NLRP3 inflammasome are elevated in those with Parkinson’s https://bempedoic-acid98765.blogprodesign.com/50341827/bi-2852-no-further-a-mystery